"While it’s encouraging to see Alabama seriously considering medical cannabis legislation, we recommend a number of revisions to SB 46 to better serve patients. For example, patients should not be steered to far more dangerous opiates first, as the bill currently does. In addition, the burden on doctors should be reduced to avoid dramatically depressing participation and leaving large numbers of patients behind," said Karen O'Keefe, MPP's director of state policies.